Centinel Spine, a medical device firm focused on cervical and lumbar spinal diseases, has announced the first US implantation of its prodisc C Nova cervical total disc replacement (TDR) product.
In July 2022, the prodisc C Nova received US Food and Drug Administration (FDA) approval for one-level indications.
The product is Centinel Spine’s fourth cervical TDR technology. It is also the third new cervical TDR product launched in the US by the medical device company since late 2022.
The prodisc C Vivo and prodisc C SK were introduced on a limited basis in late 2022 and have been used in over 8,000 procedures.
Together with the original prodisc C implant, launched in 2007, Centinel Spine offers a range of cervical TDR solutions worldwide, catering to spine surgery preferences and individual patient needs.
J. Alex Sielatycki, an orthopaedic spine surgeon at Steamboat Orthopedic & Spine Institute in Steamboat Springs, Colorado, conducted the first US pro disc C Nova procedure.
Centinel Spine CEO Steve Murray said: “We are delighted to make another proven prodisc cervical option available in the US Our experience with prodisc C Vivo and prodisc C SK has shown that surgeons appreciate the variety of endplate designs for their consideration and selection in treating each patient.
“And, importantly, the entire prodisc portfolio is built on the proven, safe, and reliable motion preservation design that makes prodisc such a trusted name in spine care.
“We are the only spine company exclusively focused on motion preservation, and prodisc C Nova further amplifies this commitment.”
The prodisc C Nova was co-developed by Rudolf Bertagnoli, chairman and CEO of Pro-Spine in Straubing, Germany.
First implanted in Europe in 2009, this device features a tri-keel design and flat endplates for optimal implant positioning. This design allows surgeons to accommodate the individual patient’s anatomy.
The low-profile keels enable a streamlined preparation technique and provide immediate fixation.
Centinel Spine’s prodisc is said to be the only TDR technology offering multiple motion-preserving anatomical solutions. This allows surgeons to match the disc to each patient’s anatomy for both cervical and lumbar total disc replacement.
In September, the medical device firm announced the completion of 7,500 US cases with prodisc C Vivo and prodisc C SK since their launch in September 2022.
